Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 1 561.5 JPY 0.06% Market Closed
Market Cap: 982.9B JPY

Operating Margin
Sysmex Corp

15.3%
Current
17%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
76B
/
Revenue
498.7B

Operating Margin Across Competitors

No Stocks Found

Sysmex Corp
Glance View

Market Cap
973.1B JPY
Industry
Health Care

In the bustling world of healthcare diagnostics, Sysmex Corporation stands as a beacon of innovation and precision. Originating from the vibrant city of Kobe, Japan, the company has mastered the art of transforming complex scientific processes into streamlined solutions. With roots tracing back to the 1960s, Sysmex emerged as a pioneer in the field of hematology, developing technological marvels that analyze blood components with remarkable accuracy. This precision is not merely an academic pursuit; it translates into actionable insights for medical professionals, empowering them to diagnose and monitor conditions ranging from anemia to leukemia with a high degree of reliability. As the lifeblood of medical laboratories worldwide, Sysmex's automated analyzers and testing systems are indispensable tools in pathologies, enabling swift and accurate patient care. Sysmex's business model is a symphony of product innovation and service excellence. The company thrives by blending advanced technologies with an ever-expanding portfolio of diagnostic instruments and reagents, ensuring that their systems remain both state-of-the-art and user-friendly. Revenue generation for Sysmex is a harmonious balance between instrument sales and the recurring income stream from consumables and after-sales service contracts. This dual approach not only secures initial capital from equipment sales but also ensures sustained engagement with their clients. By investing heavily in research and development, Sysmex continuously pushes the envelope in medical diagnostics, tapping into emerging fields like oncology, hemostasis, and urinalysis. In doing so, it fortifies its position as a global leader, committed to advancing healthcare outcomes through technological innovation and customer-centric practices.

Intrinsic Value
2 376.64 JPY
Undervaluation 34%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
76B
/
Revenue
498.7B
What is the Operating Margin of Sysmex Corp?

Based on Sysmex Corp's most recent financial statements, the company has Operating Margin of 15.3%.

Back to Top